- Home
- WF vs HOLX Comparison
WF vs HOLX Comparison
Compare WF & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WF
- HOLX
- Stock Information
- Founded
- WF 1899
- HOLX 1985
- Country
- WF South Korea
- HOLX United States
- Employees
- WF N/A
- HOLX N/A
- Industry
- WF Commercial Banks
- HOLX Medical Electronics
- Sector
- WF Finance
- HOLX Health Care
- Exchange
- WF Nasdaq
- HOLX Nasdaq
- Market Cap
- WF 13.5B
- HOLX 16.5B
- IPO Year
- WF N/A
- HOLX 1990
- Fundamental
- Price
- WF $53.55
- HOLX $74.19
- Analyst Decision
- WF
- HOLX Hold
- Analyst Count
- WF 0
- HOLX 15
- Target Price
- WF N/A
- HOLX $79.00
- AVG Volume (30 Days)
- WF 50.3K
- HOLX 4.7M
- Earning Date
- WF 10-29-2025
- HOLX 11-03-2025
- Dividend Yield
- WF 3.81%
- HOLX N/A
- EPS Growth
- WF 22.80
- HOLX N/A
- EPS
- WF 3.03
- HOLX 2.49
- Revenue
- WF $7,217,708,955.00
- HOLX $4,100,500,000.00
- Revenue This Year
- WF N/A
- HOLX $6.23
- Revenue Next Year
- WF $4.13
- HOLX $5.37
- P/E Ratio
- WF $6.02
- HOLX $29.81
- Revenue Growth
- WF 2.02
- HOLX 1.74
- 52 Week Low
- WF $29.44
- HOLX $51.90
- 52 Week High
- WF $57.97
- HOLX $81.13
- Technical
- Relative Strength Index (RSI)
- WF 43.74
- HOLX 70.55
- Support Level
- WF $54.26
- HOLX $73.86
- Resistance Level
- WF $55.97
- HOLX $74.28
- Average True Range (ATR)
- WF 0.96
- HOLX 0.25
- MACD
- WF 0.07
- HOLX -0.05
- Stochastic Oscillator
- WF 14.87
- HOLX 34.30
About WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. The operating segments of the company include Banking, Credit card, Capital, Investment banking, and others.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.